Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling-Reference-Cited by-同舟云学术

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Published:2017-08-14 Issue:3 Volume:32 Page:774-787
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Andersson E I,Pützer S,Yadav B,Dufva O,Khan S,He L,Sellner L^ORCID,Schrader A,Crispatzu G,Oleś M,Zhang H,Adnan-Awad S,Lagström S,Bellanger D,Mpindi J P,Eldfors S^ORCID,Pemovska T,Pietarinen P,Lauhio A,Tomska K,Cuesta-Mateos C,Faber E,Koschmieder S,Brümmendorf T H,Kytölä S,Savolainen E-R,Siitonen T,Ellonen P,Kallioniemi O^ORCID,Wennerberg K,Ding W,Stern M-H,Huber W^ORCID,Anders S^ORCID,Tang J,Aittokallio T,Zenz T,Herling M,Mustjoki S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017252.pdf

Reference49 articles.

1. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D . A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004; 104: 328–335.

2. Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 2008; 111: 328–337.

3. Dearden C . How I treat prolymphocytic leukemia. Blood 2012; 120: 538–551.

4. Hopfinger G, Busch R, Pflug N, Weit N, Westermann A, Fink AM et al. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia. Cancer 2013; 119: 2258–2267.

5. Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J et al. Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. Br J Haematol 2010; 149: 907–910.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes;Pediatric Blood & Cancer;2024-07-31

2. A Novel JAK2 Fusion in T‐Cell Prolymphocytic Leukemia;Genes, Chromosomes and Cancer;2024-06

3. Prolymphocytic Leukaemia: an Update on Biology and Treatment;Current Oncology Reports;2024-01-02

4. <i>STAT5B</i> mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia;Haematologica;2023-11-16

5. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-18